Kowa Co Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KOWA CO, and when can generic versions of KOWA CO drugs launch?
KOWA CO has one approved drug.
There are two US patents protecting KOWA CO drugs.
There are forty-nine patent family members on KOWA CO drugs in seventeen countries.
Summary for Kowa Co
International Patents: | 49 |
US Patents: | 2 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Patent Litigation for Kowa Co: | See patent lawsuits for Kowa Co |
Drugs and US Patents for Kowa Co
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-001 | Aug 3, 2009 | AB | RX | Yes | No | 7,022,713*PED | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-003 | Aug 3, 2009 | AB | RX | Yes | Yes | 7,022,713*PED | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-002 | Aug 3, 2009 | AB | RX | Yes | No | 8,557,993*PED | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-002 | Aug 3, 2009 | AB | RX | Yes | No | 7,022,713*PED | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-001 | Aug 3, 2009 | AB | RX | Yes | No | 8,557,993*PED | ⤷ Sign Up | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Kowa Co
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-002 | Aug 3, 2009 | 5,854,259 | ⤷ Sign Up |
Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-003 | Aug 3, 2009 | 5,854,259 | ⤷ Sign Up |
Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-001 | Aug 3, 2009 | 5,753,675 | ⤷ Sign Up |
Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-002 | Aug 3, 2009 | 6,465,477 | ⤷ Sign Up |
Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-002 | Aug 3, 2009 | 5,753,675 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for KOWA CO drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 1 mg, 2 mg, and 4 mg | ➤ Subscribe | 2013-08-05 |
International Patents for Kowa Co Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2011201915 | ⤷ Sign Up |
Taiwan | 201514149 | ⤷ Sign Up |
Japan | 2020169196 | ⤷ Sign Up |
Canada | 2513837 | ⤷ Sign Up |
Japan | 2014062115 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.